Continuation to איידיאיי הנפקות: Is Direct Insurance's capital cushion really thick enough?
The main article showed that refinancing removed the near-term maturity wall. This follow-up isolates the more important layer above the issuer: a 133% solvency ratio looks comfortable, but the real room above the 120% board target is narrower once you separate regulatory surplus from management headroom, dividend pace, and Tier 2 recognition limits.
What Is Still Left To Test After The Main Article
The main article established that the 2025 refinancing removed the near-term maturity wall, but did not change the basic point that holders of איידיאיי הנפקות debt still rely almost entirely on Direct Insurance. This follow-up isolates the unresolved issue one layer above the issuer: is Direct Insurance's capital cushion really thick enough to keep carrying this funding conduit without dividends, recognition limits, and payment-deferral conditions starting to matter more than the headline ratio?
The obvious number is 133%. That sounds comfortable against a 120% board target, but that is only the starting point. The same filing forces a separation between three different numbers: a NIS 488.0 million surplus above SCR, only NIS 195.2 million above the board's 120% target, and an additional dividend of about NIS 75 million approved on March 26, 2026 after the measurement date. Anyone looking only at the 133% headline misses that the relevant margin for debt holders is not the full surplus above SCR, but the much narrower layer above management's own target.
The more interesting detail is that the capital pipe raised a lot of money, but not every capital action actually widened recognized solvency headroom. In the solvency footnote, the filing says that the subordinated bank loans taken in April 2025 contributed about NIS 105 million to eligible capital after recognition limits, while the September 2025 Series ז' issuance, with net proceeds of NIS 338 million, had no impact on own funds for SCR after deduction of the amount above the regulatory cap. That is a critical distinction: the issuance vehicle can refinance debt and support funding flexibility, but it does not add recognized capital one-for-one.
133% Is Comfortable, But Not Untouchable
As of June 30, 2025, Direct Insurance reported NIS 1.952 billion of own funds for solvency purposes against an SCR requirement of NIS 1.464 billion. At the regulatory minimum level, that means a NIS 488.0 million surplus and a 133% solvency ratio. Even after material capital actions between the calculation date and publication date, the reported ratio remained 133%. This is not a distress reading.
But it is not the most reassuring version of that number either. The filing explicitly presents a 120% board target, and only NIS 195.2 million remains above that target. That is the margin that really determines how much freedom management has to keep paying dividends, absorb market volatility, or approach the next refinancing window without looking constrained. The gap between NIS 488.0 million and NIS 195.2 million is the whole point: surplus above the regulatory floor is not the same thing as surplus above the company's own operating line.
That is where the recognition cap matters. In April 2025, Direct Insurance took NIS 185 million of subordinated bank loans, but only about NIS 105 million counted toward eligible capital after the amount above the permitted cap was deducted. In September 2025, איידיאיי הנפקות issued Series ז' for net proceeds of NIS 338 million, yet the same footnote says the issuance had no impact on eligible own funds for SCR. The analytical translation is straightforward: the real constraint is not just raising subordinated capital, but how much of it is actually recognized. If that cap remains binding, the pipe supports financing flexibility, but it does not necessarily thicken the solvency cushion the market is watching.
The March Dividend Sits Directly On That Margin
There is another reason not to read NIS 195.2 million as a particularly thick cushion. The filing explains that the August 2025 and November 2025 dividends, NIS 60 million each, were already deducted from the recognized own funds shown for June 30, 2025. So this number is not a pre-distribution reading. It already comes after NIS 120 million of dividends that management chose to pay.
But the same page also says that on March 26, 2026 the board approved another dividend of about NIS 75 million. That amount is not inside the reported 133% ratio. Anyone treating the table as a fully updated capital snapshot through the publication date is reading too much into it. The company itself adds that after June 30, 2025, various macroeconomic developments occurred in Israel and abroad, and at this stage it cannot quantify their full effect on the solvency ratio.
The mechanical comparison between NIS 75 million and NIS 195.2 million does not produce a new reported solvency ratio, but it does frame the size of the margin. The March dividend equals about 38.4% of the disclosed surplus above the board target. If nothing else had changed, that surplus would fall to about NIS 120.2 million. That is still not a stress case, but it is also not the kind of cushion that deserves to be called thick without qualification.
The important point is not whether NIS 120 million is enough in the abstract. The point is that the room left above the board target is no longer especially wide relative to the pace of distributions. That is exactly why dividend policy is not a side issue here. It sits at the center of the risk for איידיאיי הנפקות.
When Payments Can Actually Be Deferred
Note 4 also sharpens another common mistake. Payment deferral for noteholders does not start merely because solvency falls below 120%. The 120% level is a management target. The actual deferral conditions sit on a very different ladder.
| Layer | What triggers deferral | What it means in practice |
|---|---|---|
| Interest only | No distributable profits at the issuer under the latest statements preceding the relevant interest payment date | There is a legal-accounting trigger at the issuer level, not only a solvency trigger at Direct Insurance |
| Principal and interest | Recognized own funds fall below 80% of SCR and the company has not completed a capital injection | This is a far harsher emergency line than the 120% board target |
| Principal and interest | The board determines there is an imminent real concern about meeting required capital, subject to prior supervisor approval | Regulatory discretion can stop payment before a formal line is broken |
| Principal and interest | The board determines there is an imminent real concern about paying higher-ranking liabilities, subject to prior supervisor approval | Liquidity pressure or senior liabilities can matter before a pure solvency event |
| Principal and interest | The supervisor orders deferral because of damage to the solvency ratio or concern about meeting SCR | In an extreme case, effective control shifts to the regulator |
That changes the risk reading. The hard contractual line is not 120%, but a much lower and more dangerous ladder. Erosion in the margin above the board target does not mean an immediate payment deferral is around the corner. It does mean the company gets closer to the stage where dividend flexibility, funding cost, and market sensitivity matter more than the headline ratio.
The filing supports that sequence from the other direction as well. In the issuer's business description, the company says that as long as principal or interest has been deferred because of deferral conditions, Direct Insurance will not make any distribution to its shareholders, and as of the report date no such conditions exist. In other words, once noteholders reach the formal extreme layer, shareholder distributions are also supposed to stop. Debt investors therefore need to monitor not just the legal deferral threshold, but the tightening process well before it.
Bottom Line
So is Direct Insurance's capital cushion really thick enough? Not in the simple sense that the 133% headline might imply. The cushion is still positive, there is still room above the board target, and nothing in the filing points to an immediate deferral event. But three things force a more careful reading: the NIS 195.2 million above the 120% target is much smaller than the surplus above SCR; Series ז' refinanced debt but did not expand eligible SCR capital; and the March 2026 dividend sits directly on that same margin, while the post-June 2025 macro effect has not yet been quantified.
So the right read is neither that the cushion is thin nor that it is comfortably thick. The right read is that the cushion is sufficient as long as Direct Insurance keeps dividend discipline, preserves good market access, and stays comfortably above the 120% target even after distributions. If one of those three conditions weakens, the market will not wait for the formal deferral trigger before repricing the risk at איידיאיי הנפקות.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.